AngioDynamics Inc expected to post a loss of 13 cents a share - Earnings Preview

AngioDynamics

31/03/2025 13:33

AngioDynamics Inc ANGO.OQ ANGO.O is expected to show a fall in quarterly revenue when it reports  results on April 2 for the period ending February 28 2025

The Latham New York-based  company is expected to report a 6.5% decrease in revenue to $70.303 million from $75.18 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for AngioDynamics Inc is for a loss of 13 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for AngioDynamics Inc is $15.00​, above​ its last closing price of $9.50. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Nov. 30 2024
-0.10
-0.11
-0.04
Beat
63.6
Aug. 31 2024
-0.15
-0.15
-0.11
Beat
25
May. 31 2024
-0.16
-0.17
-0.06
Beat
64​
Feb. 29 2024
-0.13
-0.14
-0.16
Missed
-18.3
​​Nov. 30 2023
-0.09
-0.07
-0.05
Beat
33.3
Aug. 31 2023
-0.13
-0.13
-0.12
Beat
7.7​
May. 31 2023
0.03
0.02
0.02
Met
-11.1
Feb. 28 2023
-0.01
-0.01
-0.03
Missed
-300

This summary was machine generated March 31 at 12:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)